OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study

Boehringer Ingelheim

Status

Completed

Conditions

Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Industry

Identifiers

NCT03386994

1199-0296

Details and patient eligibility

About

Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Services)

Enrollment

204 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Female and male patients ≥ 40 years of age
Patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF) according to last ATS/ERS/JRS/ALAT IPF guideline for diagnosis and management consensus
Written informed consent prior to participation

Exclusion criteria

Inability for the patient to understand or complete the written Inform Consent or patients questionnaires or to understand Spanish
Current participation in any clinical trial
Patients for whom further follow-up is not possible at the enrolling site